|
Match
|
Document |
Document Title |
|
|
5910513 |
Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions
A compound being a substituted benzyl derivative of polyalkylene polyamine and corresponding to the following formula: ##STR1## in which: n and m=2, 3 or 4, p=2 or 3, x=0, 1 or 2, R 1 and R 4 ,...
|
|
|
5900418 |
Method for treatment of obesity
A method is provided for the control of obesity comprising administering to a mammal including humans suffering from obesity an acetylcholine esterase reactivator or prodrug derivative thereof...
|
|
|
5888518 |
Method for preventing and treating coccidiosis
A method for preventing and treating parasitic infections in animals by administering a lysine analog, such as EACA, to the animals on a continuous basis. In the preferred embodiment, the method of...
|
|
|
5882731 |
Method of applying a mildewcide laden film and composition for the use therewith
A method is disclosed for applying a mildewcide compound laden film to surfaces by applying an aqueous, film-depositing composition onto said surfaces, allowing to stand momentarily, and rinsing...
|
|
|
5863912 |
Method of treatment of hormone-unresponsive metastiatic prostate cancer
Prostate cancer particularly hormone-unresponsive metastatic prostate cancer, is treated by cyclophosphamide or other normally substantially inactive agent. Potentiation of the anti-cancer activity...
|
|
|
5861435 |
Method for preventing settlement of aquatic fouling organisms
A method for preventing settlement of aquatic fouling organisms on surface of an aquatic structure without environmental hazard is provided. The method is based upon absolutely novel concept to...
|
|
|
5844002 |
Method for inducing bronchodilation using optically pure R(-) albuterol
The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is...
|
|
|
5840759 |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
|
|
|
5837736 |
Nitric oxide-releasing compounds to sensitive cancerous cells to chemotherapeutic agents
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
|
|
|
5837701 |
Composition and method for treating conditions associated with symptoms of unspecified retarded maturation
Compositions and method for treating conditions in humans associated with symptoms of unspecified retarded maturation due to chromosomal abnormalities cerebral atrophy, Huntington's Chorea,...
|
|
|
5830509 |
Microparticle complexes with 2-amino-1-phenylpropanol materials
Microparticulate carrier materials for a large and varied group of pharmaceutical and cosmetic agents are disclosed. Microdispersions of such carrier materials charged with at least one isomer or...
|
|
|
5827499 |
Determining effects of psychoactive compounds on the brain using positron emission tomography
A method of determining the effects of administering a psychoactive compound, such as a drug, on a patient's brain using imaging techniques with position emission tomography (PET) is disclosed. The...
|
|
|
5824666 |
Low PH, hydrolytically stable, cosmetic compositions containing acidic actives
The present invention relates to leave on, oil-in-water, skin care compositions, comprising: (A) from about 0.05% to about 20% of an acidic active ingredient, preferably having a solubility...
|
|
|
5817665 |
Composition and method of treating depression using naloxone or naltrexone in combination with a serotonin reuptake inhibitor
This invention relates to a composition and method for treating depression by administering to a patient a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus...
|
|
|
5814667 |
Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
|
|
|
5804595 |
Kappa opioid receptor agonists
The invention provides certain amino acid conjugates of substituted 2-phenyl-N- 1-(phenyl)-2-(1-heterocycloalkyl- or heterocycloaryl-)ethyl!acetamides useful for selectively agonizing kappa opioid...
|
|
|
5798392 |
Sulfonyl fluorides for the treatment of Alzheimer's disease
The present invention provides a pharmaceutical composition, comprising a sulfonyl fluoride and a pharmaceutically acceptable carrier. Also provided is a method of treating Alzheimer's disease in...
|
|
|
5789449 |
Treatment of symptoms associated with premenstrual disorders
There is disclosed a method for treating certain psychiatric symptoms including anger, rejection sensitivity and a lack of mental or physical energy with administration of a nontoxic dose of a...
|
|
|
5789448 |
Benzoylethylene derivative
Disclosed is a benzoylethylene derivative represented by the following formula (I) or a salt thereof. ##STR1## R 1 to R 5 : a hydrogen atom, --OR 9 (R 9 : a hydrogen atom, a C 1 -C 5 alkyl...
|
|
|
5753712 |
Treatment of migraine headaches and formulations
A method of Treatment of treating migraine headaches in humans by the administration of the compound of the formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof in a...
|
|
|
5744165 |
Nimesulide salt cyclodextrin inclusion complexes
Inclusion complexes of nimesulide alkali and alkaline earth salts with cyclodextrins and cyclodextrin derivatives are disclosed. Compositions containing the inclusion complexes, processes for the...
|
|
|
5744474 |
Treatment of incontinence
Urinary incontinence in humans is treated by administration of venlafaxine or a compound chosen from a series of aryloxy propanamines.
|
|
|
5744501 |
Method for treating late luteal phase dysphoric disorder
There is disclosed a method for treating Late Luteal Phase Dysphoric Disorder with administration of a nontoxic dose of a serotonin re-uptake blocker. Preferably, the serotonin re-uptake blocker is...
|
|
|
5719189 |
Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish
The present invention provides a medicinal feed for fish, which comprises a triphenylmethane derivative or a combination of triphenylmethane derivatives alone or in combination with at least one...
|
|
|
5712287 |
Method of treating urinary bladder dysfunctions
The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
|
|
|
5708035 |
Methods of use and compositions of R(-) fluoxetine
A method and composition are disclosed utilizing the pure R(-) isomer of fluoxetine which is a potent antidepressant and appetite suppressant substantially free of adverse effects. In addition, a...
|
|
|
5708036 |
Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
The optically pure R-isomer of the adrenergic beta-2 agonist albuterol, substantially free of its corresponding S-isomer, has been found to potently inhibit premature uterine contractions in female...
|
|
|
5684049 |
HIV-inhibiting benzeneacetamide derivatives
A compound for use as a medicine having the formula ##STR1## a pharmaceutically acceptable acid addition salt form or a stereochemically isomeric form thereof, wherein R 1 and R 2 each...
|
|
|
5681863 |
Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
Compounds of the formula: ##STR1## wherein R 1 and R 2 are each selected from the group consisting of C 1 -C 2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4...
|
|
|
5635213 |
Pharmaceutical formulation
A pharmaceutical formulation for intraduodenal administration comprising at least one phamacologically active agent, with limited solubility in water and is dispersed in an aqueous carrier....
|
|
|
5589512 |
Method for treating borderline personality disorder with serotonin re-uptake blockers
There is disclosed a method for treating borderline personality disorder in a patient by administering a nontoxic dose of a serotonin re-uptake blocker. Preferably, the serotonin re-uptake blocker...
|
|
|
5589511 |
Method for treating migraine headaches using optically pure S(+) fluoxetine
Methods and compositions are disclosed utilizing the pure S(+) isomer of fluoxetine which is a potent antidepressant and appetite suppressant substantially free of unwanted, adverse toxic or...
|
|
|
5580542 |
Method of testing for nephritis
Disclosed is an acetyltransferase activity measuring agent which contains an arylamine derivative. As the arylamine derivative, sodium p-aminohippurate can be used preferably. Use of the...
|
|
|
5565466 |
Methods for modulating the human sexual response
The invention is directed to improved methods for modulating the human sexual response by administering a vasodilator to the circulation by a route of administration that avoids the "first-pass"...
|
|
|
5561135 |
N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds
The invention relates to new N,N,N'N'-tetra-substituted-1,2-ethanediamine compounds of the general formula (I): ##STR1## wherein X is a carbonyl (CO), hydroxymethylen (CHOH) or...
|
|
|
5556857 |
Disturbance-of-consciousness improving agent
The present invention provides a disturbance-of-consciousness improving agent which is a highly effective and quick remedy and which can be administered orally. The disturbance-of-consciousness...
|
|
|
5554656 |
Disinfectant concentrates and disinfectants on amine and alcohol base and their use
The invention relates to a disinfectant concentrate which contains amine and alcohol wherein the alcohol component includes at least one glycol ether of limited miscibility with water and the amine...
|
|
|
5552162 |
Method for improvement of scar size and appearance
A method for improving the size and appearance of a scar associated with a fibromatosis, a keloid, or a hypertrophic wound healing disorder comprises stimulating collagenase activity in the scar....
|
|
|
5550107 |
Combination therapy for the treatment of estrogen-sensitive disease
A method of treatment of breast and endometrial cancer in susceptible warm-blooded animals may include inhibition of ovarian hormonal secretion by surgical (ovariectomy) or chemical (use of an LHRH...
|
|
|
5534531 |
Compounds
New compounds having the general formula I ##STR1## wherein L may be H or D; Y may be CN or ##STR2## wherein A may be H, D, alkyl with 1-4 carbon atoms, OR wherein R is H or alkyl with 1-4 carbon...
|
|
|
5530028 |
Insecticidal N'-substituted-N,N'-diacylhydrazines
Insecticidal compounds having the formula N-(2-R a -3-R b -4-R h -benzoyl)-N'-(2-R c -3-R d -4-R e -5-R f -benzoyl)-N'-R g -hydrazine wherein R a is a halo or lower alkyl; R b is lower...
|
|
|
5525633 |
Triaryl-ethylene derivatives
The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
|
|
|
5525631 |
Compositions of the ethyl ester of L-DOPA
A composition which comprises a pharmaceutically acceptable carrier and an active ingredient, such active ingredient comprising L-DOPA ethyl ester derived from its crystaline form in an amount...
|
|
|
5521220 |
Acyclic ethylenediamine derivatives
The present invention relates to novel acyclic ethylenediamine derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula ##STR1## wherein R 1 , R 2 ,...
|
|
|
5504115 |
Inhibitors of farnesyl protein transferase
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to...
|
|
|
5480912 |
Method of treating HIV-1 with α-substituted benzenemethanamine derivatives
The present invention is concerned with antiretroviral (e.g. anti HIV-1) compounds having the formula ##STR1## Pharmaceutical compositions containing said compounds of formula (I-a) or (I-b), and...
|
|
|
5462965 |
Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases
A class of heterocyclic amino-alcohol compounds is described for treatment of CNS-related diseases, namely, for use as a neuroprotective agent, to reduce neurotoxic injury associated with...
|
|
|
5459140 |
Combination preparation based on dipivalylepinephrine (DPE) for reducing intraocular pressure
A preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and carbachol (preparation 1) or...
|
|
|
5455276 |
Method for treating depression
Pharmaceutical compositions for treating psychiatric disorders are provided. The compositions include 2-phenylethylamine ("PEA") and at least one inhibitor of monoamine oxidase B. Methods for the...
|
|
|
5455266 |
Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof
The invention relates to enhanced chemotherapeutic compositions against microbial infections in fish, containing a benzylamine derivative of general formula ##STR1## wherein R 1 to R 3 are...
|